Abstract: The present disclosure provides compositions and uses thereof for treating a disease or disorder associated with CD20 expression. Treatments of this disclosure include use of a host cell expressing a fusion protein, such as an anti-CD20 CAR, optionally in combination with a CD20-specific binding molecule, a chemotherapeutic, an inhibitor of an immunosuppression component, or combinations thereof.

Abstract: The present invention provides a collapsible intermodal container stacker, comprising: a stationary section and a movable section disposed adjacent the stationary section. The stationary section comprises: a substantially upright planar face part; and a side wall securing device configured to operatively connect to a first side wall of a collapsible intermodal container and to secure the first side wall in use against or with respect to the planar face part. The movable section comprises: a track extending substantially perpendicular to the planar face part; a carriage engaged with and movable along the track, the carriage being configured to attach to a second side wall of the collapsible intermodal container in use; and a lower wall moving device configured to operatively connect to a lower wall of the collapsible intermodal container and to move the lower wall in use such that the lower wall pivots upwards.

Abstract: A collapsible intermodal container includes first and second opposing side walls, the first side wall extending substantially parallel to the second side wall. Each of the first and second side walls having a lower end portion and an upper end portion. An upper wall is hingedly attached to the upper end portion of the first side wall, and a lower wall is hingedly attached to the lower end portion of the second side wall. In an erected configuration of the container, the upper wall extends from the upper end portion of the first side wall to the upper end portion of the second side wall, and the lower wall extends from the lower end portion of the second side wall to the lower end portion of the first side wall, such that the first and second side walls are spaced apart by a first distance to define an interior for storing goods.

Abstract: A collapsible intermodal container includes first and second opposing parallel side walls, and an upper wall and a lower wall. The container has an erected configuration in which the upper wall extends from an upper end portion of the first side wall to an upper end portion of the second side wall, and the lower wall extends from a lower end portion of the second side wall to a lower end portion of the first side wall. In a collapsed configuration, the upper wall extends downwardly from the upper end portion of the first side wall to the lower end portion of the first side wall, and the lower wall extends upwardly from the lower end portion of the second side wall to the upper end portion of the second side wall. Front and rear end assemblies close front and rear ends of the container in the erected configuration and are engageable with the second side wall to secure the first side wall with respect to the second side wall.

Abstract: The present invention provides a collapsible intermodal container stacker, comprising: a stationary section and a movable section disposed adjacent the stationary section. The stationary section comprises: a substantially upright planar face part; and a side wall securing device configured to operatively connect to a first side wall of a collapsible intermodal container and to secure the first side wall in use against or with respect to the planar face part. The movable section comprises: a track extending substantially perpendicular to the planar face part; a carriage engaged with and movable along the track, the carriage being configured to attach to a second side wall of the collapsible intermodal container in use; and a lower wall moving device configured to operatively connect to a lower wall of the collapsible intermodal container and to move the lower wall in use such that the lower wall pivots upwards.

Abstract: The present disclosure provides compositions and uses thereof for treating a disease or disorder associated with CD20 expression. Treatments of this disclosure include use of a host cell expressing a fusion protein, such as an anti-CD20 CAR, optionally in combination with a CD20-specific binding molecule, a chemotherapeutic, an inhibitor of an immunosuppression component, or combinations thereof.

Abstract: The present disclosure provides compositions and uses thereof for treating a disease or disorder associated with CD20 expression. Treatments of this disclosure include use of a host cell expressing a fusion protein, such as an anti-CD20 CAR, optionally in combination with a CD20-specific binding molecule, a chemotherapeutic, an inhibitor of an immunosuppression component, or combinations thereof.

Abstract: The invention provides a collapsible intermodal container (10, 10?, 10?), comprising: first and second opposing side walls (12, 14), the first side wall (12) extending substantially parallel to the second side wall (14), each of the first and second side walls (12, 14) having a lower end portion (12b, 14b) and an upper end portion (12a, 14a); an upper wall (16) hingedly attached to the upper end portion (12b) of the first side wall (12); and a lower wall (18) hingedly attached to the lower end portion (14a) of the second side wall (14).

Abstract: The present invention provides a collapsible intermodal container stacker, comprising: a stationary section and a movable section disposed adjacent the stationary section. The stationary section comprises: a substantially upright planar face part; and a side wall securing device configured to operatively connect to a first side wall of a collapsible intermodal container and to secure the first side wall in use against or with respect to the planar face part. The movable section comprises: a track extending substantially perpendicular to the planar face part; a carriage engaged with and movable along the track, the carriage being configured to attach to a second side wall of the collapsible intermodal container in use; and a lower wall moving device configured to operatively connect to a lower wall of the collapsible intermodal container and to move the lower wall in use such that the lower wall pivots upwards.

Abstract: The present invention provides a collapsible intermodal container (10, 10?, 10?), comprising: first and second opposing parallel side walls (12, 14), the first side wall (14) being connected to the second side wall (12) such that the collapsible intermodal container is configurable between an erected configuration in which the first and second side walls (12, 14) are spaced apart by a first distance (D1) to define an interior for storing goods, and a collapsed configuration in which the first and second side walls (12, 14) are spaced apart by a second distance (D2) which is less than the first distance (D1). The collapsible intermodal container (10, 10?, 10?) further comprises front and rear end assemblies (24, 26) for closing front and rear ends of the container in the erected configuration and for controlling access to the interior, each of the front and rear end assemblies (24, 26) being hingedly attached to the first side wall (14).

Abstract: The present disclosure provides compositions and uses thereof for treating a disease or disorder associated with CD20 expression. Treatments of this disclosure include use of a host cell expressing a fusion protein, such as an anti-CD20 CAR, optionally in combination with a CD20-specific binding molecule, a chemotherapeutic, an inhibitor of an immunosuppression component, or combinations thereof.

Abstract: Compositions and methods for transport or release of therapeutic and diagnostic agents or metabolites or other analytes from cells, compartments within cells, or through cell layers or barriers are described. The compositions include a membrane barrier transport enhancing agent and are usually administered in combination with an enhancer and/or exposure to stimuli to effect disruption or altered permeability, transport or release. In a preferred embodiment, the compositions include compounds which disrupt endosomal membranes in response to the low pH in the endosomes but which are relatively inactive toward cell membranes, coupled directly or indirectly to a therapeutic or diagnostic agent. Other disruptive agents can also be used, responsive to stimuli and/or enhancers other than pH, such as light, electrical stimuli, electromagnetic stimuli, ultrasound, temperature, or combinations thereof.